Advanced Search
Contact | Corporate | Help

A Study of Pulmozyme® (Dornase Alpha) in 3- to 5-Year-Old Patients With Cystic Fibrosis

Sponsors:
  • Genentech
Phases:
  • Phase IV
IndicationsAcronym:
  • Cystic Fibrosis
Age Groups:
  • Child
Gender:
Both
Names:
  • Drug: dornase alfa
  • Drug: placebo
Enrollment:
40

Additional information about NCT00680316.


SourceSolution © 2008-2012